GlassScriptPhysician profile
Jason Joseph George
NPI 1962728253
$10,202.76
in general payments reported to CMS, 2019-2025
43 companies · $1,844 in 2025
The $1,844 reported for 2025 was more than what 82% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,032 · 2020: $918 · 2021: $1,020 · 2022: $1,330 · 2023: $1,852 · 2024: $2,208 · 2025: $1,844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,885 · Education: $18.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,885.41 |
| Education | $18.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,777.60 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $959.44 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $645.68 | 2019-2025 | Wainua, Farxiga |
| Merck Sharp & Dohme LLC | $591.99 | 2021-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $429.04 | 2019-2025 | Lifevest |
| Alnylam Pharmaceuticals INC. | $409.21 | 2023-2025 | Amvuttra, Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $406.68 | 2019-2025 | |
| Pfizer INC. | $358.11 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $350.83 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $329.00 | 2019-2025 | Repatha, Repatha |
| Heartflow, INC. | $293.03 | 2022-2025 | Ffrct |
| Medtronic, INC. | $282.46 | 2021-2025 | Venaseal, Closurefast |
| Cashflow Solutions, LLC | $268.40 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Philips North America LLC | $256.46 | 2020-2025 | (Ck4) Mcot, Ecc Solutions |
| Lilly USA, LLC | $242.48 | 2023-2024 | Mounjaro, Trulicity, Zepbound |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $231.07 | 2020-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $228.45 | 2019-2023 | |
| Scpharmaceuticals INC. | $203.61 | 2023-2025 | |
| Abbott Laboratories | $201.11 | 2019-2025 | Merlin@Home, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Esperion Therapeutics, INC. | $199.48 | 2021-2024 | Nexletol |
| Amarin Pharma, INC. | $198.03 | 2019-2021 | |
| Tactile Systems Technology INC | $188.83 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Edwards Lifesciences Corporation | $176.39 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $153.24 | 2019-2020 | |
| Boston Scientific Corporation | $147.64 | 2020-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Kiniksa Pharmaceuticals International, Plc | $110.25 | 2024 | Arcalyst |
| Novo Nordisk INC | $67.65 | 2024 | Wegovy |
| Regeneron Healthcare Solutions, INC. | $59.87 | 2019-2023 | Evkeeza |
| Lexicon Pharmaceuticals, INC. | $51.10 | 2023-2024 | Inpefa |
| Baxter Healthcare | $47.44 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Bridgebio Pharma, INC. | $47.37 | 2025 | Attruby |
| Chiesi USA, INC. | $40.81 | 2024-2025 | Juxtapid |
| Lundbeck LLC | $36.92 | 2020 | |
| Amryt Pharma Holdings LTD | $32.89 | 2022 | |
| Abiomed | $31.86 | 2023-2024 | Impella |
| Glaxosmithkline, LLC. | $31.77 | 2025 | Shingrix |
| Angiodynamics, INC. | $20.76 | 2021 | |
| Stryker Corporation | $20.60 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kiniksa Pharmaceuticals, LTD. | $18.84 | 2023 | Arcalyst |
| Inari Medical, INC. | $17.09 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $14.65 | 2024 | Venclose Maven Catheter |
| Irhythm Technologies, INC. | $13.48 | 2019 | |
| Bardy Diagnostics, INC. | $11.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason George listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.